Heparin API - Global and China Top Players Market Share and Ranking 2023
This report studies and analyses global Heparin API status and future trends, helps the client to determine the Heparin API market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Heparin API, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Heparin API market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Heparin API sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Heparin API sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Heparin API key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Heparin API key producing regions, capacity, production, and year over year growth
(6) Heparin API industry chains, upstream, midstream and downstream
According to Latest Research, the global market for Heparin API should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Heparin API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Heparin API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Venous Thrombosis grew percent to account for percent of the total market sales, and Acute Coronary Syndrome grew percent.
Key Players Driving the Market:
Sanofi
Pfizer
Rovi Pharma
Merz Pharmaceuticals
Alfasigma
SPL
Bioiberica
China Resources Sanjiu Pharmaceutical
Kivipharm
Baiyu Pharmaceutical
Jida Pharmaceutical
SL Pharmaceutical
Jiuyuan Gene Engineering
Qianhong Biopharma
Harbin Pharmaceutical Group Bioengineering
New Time Pharmaceutical
Dongcheng Biochemicals
Hepalink Pharmaceutical
By Product Type, the market is primarily segmented into:
Heparin Sodium
Enoxaparin
Nadroparin
Dalteparin
Others
By Applications, the market is segmented into:
Venous Thrombosis
Acute Coronary Syndrome
Atrial Fibrillation
Cardiovascular Surgery
Hemodialysis
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Heparin API product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Heparin API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Heparin API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Heparin API, percent & CAGR, 2018-2029
Chapter 5: Heparin API industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Heparin API Definition
1.2 Global Heparin API Market Size and Forecast
1.2.1 By Consumption Value, Global Heparin API Market Size，2018-2029
1.2.2 By Sales Quantity, Global Heparin API Market Size，2018-2029
1.2.3 Global Heparin API Average Selling Price (ASP)，2018-2029
1.3 China Heparin API Market Size and Forecast
1.3.1 By Consumption Value, China Heparin API Market Size，2018-2029
1.3.2 By Sales Quantity, China Heparin API Market Size，2018-2029
1.3.3 China Heparin API Average Selling Price (ASP)， 2018-2029
1.4 Share of China Heparin API Market with Respect to the Global Market
1.4.1 By Consumption Value, China Heparin API Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Heparin API Market Share in Global, 2018-2029
1.4.3 Heparin API Market Size: China VS Global, 2018-2029
1.5 Heparin API Market Dynamics
1.5.1 Heparin API Market Drivers
1.5.2 Heparin API Market Restraints
1.5.3 Heparin API Industry Trends
1.5.4 Heparin API Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Heparin API, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Heparin API, Global Market Share by Company, 2018-2023
2.3 Heparin API Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Heparin API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Heparin API Concentration Ratio
2.6 Global Heparin API Mergers & Acquisitions, Expansion Plans
2.7 Global Heparin API Manufacturers Product Type
2.8 Head Office and Heparin API Production Site of Key Manufacturer
2.9 Heparin API Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Heparin API, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Heparin API, China Market Share by Company, 2018-2023
3.3 China Heparin API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Heparin API Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Heparin API Capacity by Region
4.3 Global Heparin API Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Heparin API Production by Region, 2018-2029
4.5 Global Heparin API Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Heparin API Industry Chain
5.2 Heparin API Upstream Analysis
5.2.1 Heparin API Core Raw Materials
5.2.2 Main Manufacturers of Heparin API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Heparin API Production Mode
5.6 Heparin API Procurement Model
5.7 Heparin API Industry Sales Model and Sales Channels
5.7.1 Heparin API Sales Model
5.7.2 Heparin API Typical Distributors
6 Sights by Type
6.1 Heparin API Classification
6.1.1 Heparin Sodium
6.1.2 Enoxaparin
6.1.3 Nadroparin
6.1.4 Dalteparin
6.1.5 Others
6.2 By Type, Global Heparin API Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Heparin API Consumption Value, 2018-2029
6.4 By Type, Global Heparin API Sales Quantity, 2018-2029
6.5 By Type, Global Heparin API Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Heparin API Segment by Application
7.1.1 Venous Thrombosis
7.1.2 Acute Coronary Syndrome
7.1.3 Atrial Fibrillation
7.1.4 Cardiovascular Surgery
7.1.5 Hemodialysis
7.1.6 Others
7.2 By Application, Global Heparin API Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Heparin API Consumption Value, 2018-2029
7.4 By Application, Global Heparin API Sales Quantity, 2018-2029
7.5 By Application, Global Heparin API Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Heparin API Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Heparin API Consumption Value, 2018-2029
8.3 By Region, Global Heparin API Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Heparin API & Forecasts, 2018-2029
8.4.2 By Country, North America Heparin API Market Size Market Share
8.5 Europe
8.5.1 Europe Heparin API Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Heparin API Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Heparin API Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Heparin API Market Size Market Share
8.7 South America
8.7.1 South America Heparin API Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Heparin API Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Heparin API Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Heparin API Consumption Value, 2018-2029
9.3 By Country, Global Heparin API Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Heparin API Market Size, 2018-2029
9.4.2 By Type, U.S. Heparin API Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Heparin API Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Heparin API Market Size, 2018-2029
9.5.2 By Type, Europe Heparin API Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Heparin API Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Heparin API Market Size, 2018-2029
9.6.2 By Type, China Heparin API Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Heparin API Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Heparin API Market Size, 2018-2029
9.7.2 By Type, Japan Heparin API Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Heparin API Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Heparin API Market Size, 2018-2029
9.8.2 By Type, South Korea Heparin API Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Heparin API Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Heparin API Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Heparin API Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Heparin API Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Heparin API Market Size, 2018-2029
9.10.2 By Type, India Heparin API Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Heparin API Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Heparin API Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Heparin API Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Heparin API Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Sanofi
10.1.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.1.2 Sanofi Heparin API Models, Specifications, and Application
10.1.3 Sanofi Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Sanofi Company Profile and Main Business
10.1.5 Sanofi Recent Developments
10.2 Pfizer
10.2.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.2.2 Pfizer Heparin API Models, Specifications, and Application
10.2.3 Pfizer Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Pfizer Company Profile and Main Business
10.2.5 Pfizer Recent Developments
10.3 Rovi Pharma
10.3.1 Rovi Pharma Company Information, Head Office, Market Area, and Industry Position
10.3.2 Rovi Pharma Heparin API Models, Specifications, and Application
10.3.3 Rovi Pharma Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Rovi Pharma Company Profile and Main Business
10.3.5 Rovi Pharma Recent Developments
10.4 Merz Pharmaceuticals
10.4.1 Merz Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.4.2 Merz Pharmaceuticals Heparin API Models, Specifications, and Application
10.4.3 Merz Pharmaceuticals Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Merz Pharmaceuticals Company Profile and Main Business
10.4.5 Merz Pharmaceuticals Recent Developments
10.5 Alfasigma
10.5.1 Alfasigma Company Information, Head Office, Market Area, and Industry Position
10.5.2 Alfasigma Heparin API Models, Specifications, and Application
10.5.3 Alfasigma Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Alfasigma Company Profile and Main Business
10.5.5 Alfasigma Recent Developments
10.6 SPL
10.6.1 SPL Company Information, Head Office, Market Area, and Industry Position
10.6.2 SPL Heparin API Models, Specifications, and Application
10.6.3 SPL Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 SPL Company Profile and Main Business
10.6.5 SPL Recent Developments
10.7 Bioiberica
10.7.1 Bioiberica Company Information, Head Office, Market Area, and Industry Position
10.7.2 Bioiberica Heparin API Models, Specifications, and Application
10.7.3 Bioiberica Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Bioiberica Company Profile and Main Business
10.7.5 Bioiberica Recent Developments
10.8 China Resources Sanjiu Pharmaceutical
10.8.1 China Resources Sanjiu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.8.2 China Resources Sanjiu Pharmaceutical Heparin API Models, Specifications, and Application
10.8.3 China Resources Sanjiu Pharmaceutical Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 China Resources Sanjiu Pharmaceutical Company Profile and Main Business
10.8.5 China Resources Sanjiu Pharmaceutical Recent Developments
10.9 Kivipharm
10.9.1 Kivipharm Company Information, Head Office, Market Area, and Industry Position
10.9.2 Kivipharm Heparin API Models, Specifications, and Application
10.9.3 Kivipharm Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Kivipharm Company Profile and Main Business
10.9.5 Kivipharm Recent Developments
10.10 Baiyu Pharmaceutical
10.10.1 Baiyu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Baiyu Pharmaceutical Heparin API Models, Specifications, and Application
10.10.3 Baiyu Pharmaceutical Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Baiyu Pharmaceutical Company Profile and Main Business
10.10.5 Baiyu Pharmaceutical Recent Developments
10.11 Jida Pharmaceutical
10.11.1 Jida Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.11.2 Jida Pharmaceutical Heparin API Models, Specifications, and Application
10.11.3 Jida Pharmaceutical Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Jida Pharmaceutical Company Profile and Main Business
10.11.5 Jida Pharmaceutical Recent Developments
10.12 SL Pharmaceutical
10.12.1 SL Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.12.2 SL Pharmaceutical Heparin API Models, Specifications, and Application
10.12.3 SL Pharmaceutical Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 SL Pharmaceutical Company Profile and Main Business
10.12.5 SL Pharmaceutical Recent Developments
10.13 Jiuyuan Gene Engineering
10.13.1 Jiuyuan Gene Engineering Company Information, Head Office, Market Area, and Industry Position
10.13.2 Jiuyuan Gene Engineering Heparin API Models, Specifications, and Application
10.13.3 Jiuyuan Gene Engineering Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Jiuyuan Gene Engineering Company Profile and Main Business
10.13.5 Jiuyuan Gene Engineering Recent Developments
10.14 Qianhong Biopharma
10.14.1 Qianhong Biopharma Company Information, Head Office, Market Area, and Industry Position
10.14.2 Qianhong Biopharma Heparin API Models, Specifications, and Application
10.14.3 Qianhong Biopharma Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Qianhong Biopharma Company Profile and Main Business
10.14.5 Qianhong Biopharma Recent Developments
10.15 Harbin Pharmaceutical Group Bioengineering
10.15.1 Harbin Pharmaceutical Group Bioengineering Company Information, Head Office, Market Area, and Industry Position
10.15.2 Harbin Pharmaceutical Group Bioengineering Heparin API Models, Specifications, and Application
10.15.3 Harbin Pharmaceutical Group Bioengineering Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Harbin Pharmaceutical Group Bioengineering Company Profile and Main Business
10.15.5 Harbin Pharmaceutical Group Bioengineering Recent Developments
10.16 New Time Pharmaceutical
10.16.1 New Time Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.16.2 New Time Pharmaceutical Heparin API Models, Specifications, and Application
10.16.3 New Time Pharmaceutical Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 New Time Pharmaceutical Company Profile and Main Business
10.16.5 New Time Pharmaceutical Recent Developments
10.17 Dongcheng Biochemicals
10.17.1 Dongcheng Biochemicals Company Information, Head Office, Market Area, and Industry Position
10.17.2 Dongcheng Biochemicals Heparin API Models, Specifications, and Application
10.17.3 Dongcheng Biochemicals Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Dongcheng Biochemicals Company Profile and Main Business
10.17.5 Dongcheng Biochemicals Recent Developments
10.18 Hepalink Pharmaceutical
10.18.1 Hepalink Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.18.2 Hepalink Pharmaceutical Heparin API Models, Specifications, and Application
10.18.3 Hepalink Pharmaceutical Heparin API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Hepalink Pharmaceutical Company Profile and Main Business
10.18.5 Hepalink Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Heparin API Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Heparin API Market Restraints
Table 3. Heparin API Market Trends
Table 4. Heparin API Industry Policy
Table 5. Global Heparin API Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Heparin API Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Heparin API Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Heparin API Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Heparin API Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Heparin API Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Heparin API Mergers & Acquisitions, Expansion Plans
Table 12. Global Heparin API Manufacturers Product Type
Table 13. Head Office and Heparin API Production Site of Key Manufacturer
Table 14. Heparin API Capacity of Major Manufacturers and Future Plan
Table 15. China Heparin API Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Heparin API Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Heparin API Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Heparin API Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Heparin API Production by Region, 2018-2023, (K Units)
Table 20. Global Heparin API Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Heparin API Upstream (Raw Materials)
Table 22. Global Heparin API Typical Customers
Table 23. Heparin API Typical Distributors
Table 24. By Type, Global Heparin API Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Heparin API Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Heparin API Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Heparin API Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Heparin API Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Heparin API Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Heparin API Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Heparin API Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Heparin API Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Heparin API Sales Quantity Market Share, 2018-2029
Table 34. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 35. Sanofi Heparin API Models, Specifications, and Application
Table 36. Sanofi Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Sanofi Company Profile and Main Business
Table 38. Sanofi Recent Developments
Table 39. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 40. Pfizer Heparin API Models, Specifications, and Application
Table 41. Pfizer Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Company Profile and Main Business
Table 43. Pfizer Recent Developments
Table 44. Rovi Pharma Company Information, Head Office, Market Area, and Industry Position
Table 45. Rovi Pharma Heparin API Models, Specifications, and Application
Table 46. Rovi Pharma Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Rovi Pharma Company Profile and Main Business
Table 48. Rovi Pharma Recent Developments
Table 49. Merz Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 50. Merz Pharmaceuticals Heparin API Models, Specifications, and Application
Table 51. Merz Pharmaceuticals Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Merz Pharmaceuticals Company Profile and Main Business
Table 53. Merz Pharmaceuticals Recent Developments
Table 54. Alfasigma Company Information, Head Office, Market Area, and Industry Position
Table 55. Alfasigma Heparin API Models, Specifications, and Application
Table 56. Alfasigma Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Alfasigma Company Profile and Main Business
Table 58. Alfasigma Recent Developments
Table 59. SPL Company Information, Head Office, Market Area, and Industry Position
Table 60. SPL Heparin API Models, Specifications, and Application
Table 61. SPL Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. SPL Company Profile and Main Business
Table 63. SPL Recent Developments
Table 64. Bioiberica Company Information, Head Office, Market Area, and Industry Position
Table 65. Bioiberica Heparin API Models, Specifications, and Application
Table 66. Bioiberica Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Bioiberica Company Profile and Main Business
Table 68. Bioiberica Recent Developments
Table 69. China Resources Sanjiu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 70. China Resources Sanjiu Pharmaceutical Heparin API Models, Specifications, and Application
Table 71. China Resources Sanjiu Pharmaceutical Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. China Resources Sanjiu Pharmaceutical Company Profile and Main Business
Table 73. China Resources Sanjiu Pharmaceutical Recent Developments
Table 74. Kivipharm Company Information, Head Office, Market Area, and Industry Position
Table 75. Kivipharm Heparin API Models, Specifications, and Application
Table 76. Kivipharm Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Kivipharm Company Profile and Main Business
Table 78. Kivipharm Recent Developments
Table 79. Baiyu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 80. Baiyu Pharmaceutical Heparin API Models, Specifications, and Application
Table 81. Baiyu Pharmaceutical Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Baiyu Pharmaceutical Company Profile and Main Business
Table 83. Baiyu Pharmaceutical Recent Developments
Table 84. Jida Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 85. Jida Pharmaceutical Heparin API Models, Specifications, and Application
Table 86. Jida Pharmaceutical Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Jida Pharmaceutical Company Profile and Main Business
Table 88. Jida Pharmaceutical Recent Developments
Table 89. SL Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 90. SL Pharmaceutical Heparin API Models, Specifications, and Application
Table 91. SL Pharmaceutical Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. SL Pharmaceutical Company Profile and Main Business
Table 93. SL Pharmaceutical Recent Developments
Table 94. Jiuyuan Gene Engineering Company Information, Head Office, Market Area, and Industry Position
Table 95. Jiuyuan Gene Engineering Heparin API Models, Specifications, and Application
Table 96. Jiuyuan Gene Engineering Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Jiuyuan Gene Engineering Company Profile and Main Business
Table 98. Jiuyuan Gene Engineering Recent Developments
Table 99. Qianhong Biopharma Company Information, Head Office, Market Area, and Industry Position
Table 100. Qianhong Biopharma Heparin API Models, Specifications, and Application
Table 101. Qianhong Biopharma Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Qianhong Biopharma Company Profile and Main Business
Table 103. Qianhong Biopharma Recent Developments
Table 104. Harbin Pharmaceutical Group Bioengineering Company Information, Head Office, Market Area, and Industry Position
Table 105. Harbin Pharmaceutical Group Bioengineering Heparin API Models, Specifications, and Application
Table 106. Harbin Pharmaceutical Group Bioengineering Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Harbin Pharmaceutical Group Bioengineering Company Profile and Main Business
Table 108. Harbin Pharmaceutical Group Bioengineering Recent Developments
Table 109. New Time Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 110. New Time Pharmaceutical Heparin API Models, Specifications, and Application
Table 111. New Time Pharmaceutical Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. New Time Pharmaceutical Company Profile and Main Business
Table 113. New Time Pharmaceutical Recent Developments
Table 114. Dongcheng Biochemicals Company Information, Head Office, Market Area, and Industry Position
Table 115. Dongcheng Biochemicals Heparin API Models, Specifications, and Application
Table 116. Dongcheng Biochemicals Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Dongcheng Biochemicals Company Profile and Main Business
Table 118. Dongcheng Biochemicals Recent Developments
Table 119. Hepalink Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 120. Hepalink Pharmaceutical Heparin API Models, Specifications, and Application
Table 121. Hepalink Pharmaceutical Heparin API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Hepalink Pharmaceutical Company Profile and Main Business
Table 123. Hepalink Pharmaceutical Recent Developments
List of Figures
Figure 1. Heparin API Picture
Figure 2. Global Heparin API Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Heparin API Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Heparin API Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Heparin API Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Heparin API Sales Quantity (K Units) & (2018-2029)
Figure 7. China Heparin API Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Heparin API Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Heparin API Market Share of Global, 2018-2029
Figure 10. Global Heparin API Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Heparin API Key Participants, Market Share, 2022
Figure 12. Global Heparin API Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Heparin API Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Heparin API Production Market Share & Forecast by Region, 2018-2029
Figure 15. Heparin API Industry Chain
Figure 16. Heparin API Procurement Model
Figure 17. Heparin API Sales Model
Figure 18. Heparin API Sales Channels, Direct Sales, and Distribution
Figure 19. Heparin Sodium
Figure 20. Enoxaparin
Figure 21. Nadroparin
Figure 22. Dalteparin
Figure 23. Others
Figure 24. By Type, Global Heparin API Consumption Value, 2018-2029, US$ Million
Figure 25. By Type, Global Heparin API Consumption Value Market Share, 2018-2029
Figure 26. By Type, Global Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 27. By Type, Global Heparin API Sales Quantity Market Share, 2018-2029
Figure 28. By Type, Global Heparin API Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 29. Venous Thrombosis
Figure 30. Acute Coronary Syndrome
Figure 31. Atrial Fibrillation
Figure 32. Cardiovascular Surgery
Figure 33. Hemodialysis
Figure 34. Others
Figure 35. By Application, Global Heparin API Consumption Value, 2018-2029, US$ Million
Figure 36. By Application, Global Heparin API Consumption Value Market Share, 2018-2029
Figure 37. By Application, Global Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 38. By Application, Global Heparin API Sales Quantity Market Share, 2018-2029
Figure 39. By Application, Global Heparin API Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 40. By Region, Global Heparin API Consumption Value Market Share, 2018-2029
Figure 41. By Region, Global Heparin API Sales Quantity Market Share, 2018-2029
Figure 42. North America Heparin API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Heparin API Consumption Value Market Share, 2022
Figure 44. Europe Heparin API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Heparin API Consumption Value Market Share, 2022
Figure 46. Asia Pacific Heparin API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Heparin API Consumption Value Market Share, 2022
Figure 48. South America Heparin API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Heparin API Consumption Value Market Share, 2022
Figure 50. Middle East & Africa Heparin API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, U.S. Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 54. Europe Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Europe Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Europe Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 57. China Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, China Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, China Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 60. Japan Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Japan Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Japan Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 63. South Korea Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, South Korea Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, South Korea Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 66. Southeast Asia Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Southeast Asia Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Southeast Asia Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 69. India Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 70. By Type, India Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, India Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 72. Middle East & Africa Heparin API Sales Quantity, 2018-2029, (K Units)
Figure 73. By Type, Middle East & Africa Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 74. By Application, Middle East & Africa Heparin API Sales Quantity Market Share, 2022 VS 2029
Figure 75. Research Methodology
Figure 76. Breakdown of Primary Interviews
Figure 77. Bottom-up and Top-down Approaches
Figure 78. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|